Related Experiment Video
Updated: Mar 15, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Multiple primary colorectal cancer: Clinical aspects].
N V Soldatkina1, O I Kit1, Yu A Gevorkyan1
1Rostov Research Institute of Oncology, Ministry of Health of Russia, Rostov-on-Don, Russia.
This study analyzed clinical features of multiple primary colorectal cancers (CRC). Synchronous CRC was more common, often in the sigmoid colon and rectum, with specific associated cancers noted in men and women.
Area of Science:
- Oncology
- Gastroenterology
- Clinical Medicine
Background:
- Multiple primary colorectal cancers (CRC) present unique diagnostic and management challenges.
- Understanding the clinical characteristics of synchronous and metachronous CRC is crucial for patient care.
Purpose of the Study:
- To define the clinical characteristics of synchronous and metachronous colorectal cancer (CRC).
- To identify patterns and associations of multiple primary CRC in relation to patient demographics and other cancers.
Main Methods:
- Retrospective analysis of clinical, biological, and morphological data from 150 patients with multiple primary CRC (T1-4N0-2M0-1).
- Comparison of characteristics between synchronous and metachronous tumor presentations.
Main Results:
- Multiple primary tumors constituted 6.01% of all CRC cases.
- Synchronous CRC (63.75%) was more prevalent, predominantly in the sigmoid colon and rectum.
- Specific cancer comorbidities were observed: synchronous CRC with breast tumors in women and kidney cancer in men; metachronous CRC with genital tumors in women and gastric cancer in men.
Conclusions:
- The identified clinical characteristics of multiple primary colorectal tumors can inform diagnostic and follow-up strategies.
- Incorporating these findings into cancer screening and surveillance programs may improve early detection and treatment outcomes.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

